Provider
QP101-22 Update for New to Market Medical Drugs: Lecanemab and Lifileucel
Program effective Date: Dec 16, 2022
Search Results
Displaying 1641 - 1650 of 3698 results
Provider
QP108-22 MHCP Pharmacy Benefit Exclusion-Xolair
Program effective Date: Dec 14, 2022
Provider
QP107-22 PCA Agency Requirements
Program effective Date: Dec 14, 2022
Provider
QP111-22 Commercial Pharmacy Benefit Exclusion for Tzield™
Program effective Date: Dec 28, 2022
Provider
QP112-22 MHCP Pharmacy Benefit Exclusion for Elahere™ and Tzield™
Program effective Date: Dec 28, 2022
Provider
Radicava (edaravone) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Jul 01, 2025
Provider
Vtama (tapinarof) - Commercial
Prior Authorization
Program effective Date: Jun 01, 2025
Provider
P5-23 Screening, Brief Intervention, and Referral to Treatment (SBIRT) effective January 1, 2023
Program effective Date: Jan 02, 2023
Provider
2023 January Bulletins
Program effective Date: Jan 02, 2023